Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism.
Baufreton J, Milekovic T, Li Q, McGuire S, Moraud EM, Porras G, Sun S, Ko WKD, Chazalon M, Morin S, Normand E, Farjot G, Milet A, Pype J, Pioli E, Courtine G, Bessière B, Bezard E.
Baufreton J, et al. Among authors: ko wkd.
Mov Disord. 2018 Oct;33(10):1632-1642. doi: 10.1002/mds.27404. Epub 2018 May 14.
Mov Disord. 2018.
PMID: 29756234
Free PMC article.
Parkinson's disease motor symptoms are treated with levodopa, but long-term treatment leads to disabling dyskinesia. Altered synaptic transmission and maladaptive plasticity of corticostriatal glutamatergic projections play a critical role in the pathophysiology of dyskine …
Parkinson's disease motor symptoms are treated with levodopa, but long-term treatment leads to disabling dyskinesia. Altered synaptic …